Q
QuantAbundanciaAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

27,504 signal articles · 193 in last 24h · 133,239 total before filter · latest 58m ago
193last 24h
1096last 7d
187● bullish (7d)
121● bearish (7d)
208publishers
AllMacro269Earnings388M&A69Regulatory28Product8Analyst19
✕ clear all filtersSentiment:bullishneutralbearishshow all (incl. clickbait)
Is Chipotle a Buy, Sell, or Hold After 2 Years of Volatility?
24/7 Wall St.28d agoneutral
Is Chipotle a Buy, Sell, or Hold After 2 Years of Volatility?

Chipotle's share price has swung wildly for two years, and now management is buying back stock aggressively near current levels while Wall Street eyes a 27% upside. The real question is whether the operational recovery has enough traction to survive margin pressure, a fragile consumer, and fresh food safety concerns.

AZN rebounds after report dismisses AstraZeneca-Bristol Myers merger speculation
InvestorsHub29d agobearish
AZN rebounds after report dismisses AstraZeneca-Bristol Myers merger speculation

AstraZeneca (NASDAQ:AZN) shares climbed around 6% on Wednesday after Reuters reported that there are “no discussions” between the company and Bristol Myers Squibb (NYSE:BMY) regarding a potential merger, contradicting recent speculation that had unsettled investors. The report eased concerns surrounding a deal that, if completed, would have created a pharmaceutical group valued at close to $400 billion.

Investing.com29d agoneutral
Chipotle gains 3.5% as Minnesota health officials clear chain in outbreak

Investing.com -- Chipotle Mexican Grill (NYSE: CMG) is signaling a 3.5% pre-market rebound ahead of Wednesday’s open after Minnesota health officials confirmed they have no ongoing concerns with the chain. The official clearance offers the clearest exoneration yet following Tuesday’s 9.72% plunge — the stock’s steepest single-day drop in nine months. The recovery stems from an August 5 SEC filing in which Chipotle revealed that the Minnesota Department of Health (MDH) had completely cleared it o

Investing.com29d agobullish
AZN spikes 6% after report it denies AstraZeneca-BMS merger talks

AstraZeneca (NASDAQ: AZN) and Bristol Myers Squibb (NYSE: BMY) are the two directly affected public companies; AZN bears the most immediate price risk given it absorbed a roughly 9% single-day selloff on Monday when the merger speculation first emerged, while BMY shareholders were widely viewed as the primary beneficiaries of any combination.

Caption: Chipotle is removing jalapeños from its menu in Minnesota after potentially being linked to the Salmonella outbreak, according to reports. 🌶️

The stock dipped nearly 9% following the news on Tuesday.

Explore more premium news and analysis on Chipotle in AlphaSpace:
Yahoo Finance Video29d agoneutralVIDEO
Caption: Chipotle is removing jalapeños from its menu in Minnesota after potentially being linked to the Salmonella outbreak, according to reports. 🌶️ The stock dipped nearly 9% following the news on Tuesday. Explore more premium news and analysis on Chipotle in AlphaSpace:

Caption: Chipotle is removing jalapeños from its menu in Minnesota after potentially being linked to the Salmonella outbreak, according to reports. 🌶️ The stock dipped nearly 9% following the news on Tuesday. Explore more premium news and analysis on Chipotle in AlphaSpace: